Latest Press Releases & News

RegCell Announces Two Peer-Reviewed Publications Supporting its Robust Scientific Foundation on Antigen-Specific Tolerance to Treat Autoimmune Diseases

November 13, 2025

Press Releases

RegCell today announced the publications of two studies in Science Translational Medicine from its scientific founder and member of its Board of Directors, Shimon Sakaguchi, MD, Ph.D.,…

RegCell Scientific Founder and Board Member Dr. Shimon Sakaguchi Awarded Nobel Prize in Physiology or Medicine

October 9, 2025

Press Releases

RegCell today announced the closing of an oversubscribed seed round and its transition to a U.S.-based company.

Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition

March 18, 2025

Press Releases

RegCell today announced the closing of an oversubscribed seed round and its transition to a U.S.-based company.

RegCell Appoints Leading T-Cell Therapy Expert Steven B. Kanner, Ph.D., to Board of Directors

April 3, 2024

Press Releases

RegCell today announced the appointment of Steven B. Kanner, Ph.D., to the company’s Board of Directors. Dr. Kanner’s wealth of expertise in the biotech and…

RegCell Appoints Experienced Life Science Executive and Entrepreneur Michael McCullar, Ph.D., MBA, as its New Chief Executive Officer

October 19, 2023

Press Releases

Regcell today announced the appointment of Michael V. McCullar, Ph.D., MBA as its new President, Chief Executive Officer, and Representative Director. “I am honored to…

Scientists rehabilitate disease-causing T cells into tolerance builders

November 3, 2025

News

BioWorld

Tamra Sami

For 75 years, the standard tools for autoimmune disease have consisted of steroids, cytotoxics and broad biologics that tamp down the entire immune system. They…

Science Spotlight: Autoimmune Treg therapy from Nobel Prize winner Sakaguchi

October 29, 2025

News

BioCentury

Danielle Golovin

Researchers from Keio University School of Medicine and Osaka University, including RegCell Inc.’s scientific founder and co-winner of the 2025 Nobel Prize in Physiology or…

In 2 papers, Nobel winner debuts technique to turn rogue T cells into their own treatment

October 23, 2025

News

Fierce Biotech

Darren Incorvaia

Even for a newly minted Nobel laureate, downtime is hard to find. Just a few weeks after winning the 2025 Nobel Prize in Physiology or…

Viewpoint: Japan is on the cusp of a tech commercialisation revolution

October 21, 2025

News

Deal Street Asia

Raymond Woo

Over the past month, Japan was in celebration when Professor Shimon Sakaguchi of the University of Osaka (and formerly from Kyoto University) won the Nobel…

Nobel winner Sakaguchi hopes to harness regulatory T-cells against cancer

October 18, 2025

News

Nikkei

Yasuki Okamoto, Yuki Misumi, Satoshi Kawahara

TOKYO — Osaka University professor Shimon Sakaguchi, who shared this year’s Nobel Prize in physiology or medicine for the discovery of regulatory T-cells, told Nikkei…

Clarivate Repeats Success in Nobel Prize Predictions with 6 New Laureates Identified by Citation Laureates Program

October 14, 2025

News

Clarivate

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today celebrates the continued success of its annual Citation Laureates program, following the accurate identification of 6 Nobel…

Trio win Nobel economics prize for work on innovation, growth and ‘creative destruction’

October 13, 2025

News

Reuters

Johan Ahlander, Jonathan Allen, Simon Johnson

Joel Mokyr, Philippe Aghion and Peter Howitt won the 2025 Nobel economics prize on Monday for their work on how innovation and the forces of…

Nobel winners still pushing boundaries in Treg innovation

October 11, 2025

News

BioCentury

Tierney Baum

Paradigm-shifting research into Tregs and peripheral immune tolerance helped launch entire spaces of therapeutic development, including cancer immunotherapy, organ transplant rejection and autoimmune disease. Almost…

Dr. Michael McCullar, PhD – CEO, RegCell – Restoring Self Tolerance To The Immune System

October 10, 2025

News

Progress, Potential and Possibilities

Ira Pastor

Dr. Michael McCullar, PhD is Chief Executive Officer of RegCell, a biotechnology company has developed a best-in-class proprietary platform that allows the generation of epigenetically…

Shifumi Sakaguchi’s company will conduct the first clinical trial of regulatory T cells

October 10, 2025

News

Nikkei

RegCell, a startup founded by Shifumi Sakaguchi, a distinguished professor at Osaka University in Japan who has been nominated for the Nobel Prize in Physiology…

How T regs fueled a new class of immunology companies

October 9, 2025

News

Chemical & Engineering News

Rowan Walrath

It was 1994, and geneticist Mary E. Brunkow, who this week became a newly minted Nobel laureate, had just started at Darwin Molecular after completing…

Bio Japan 2025: Nobel Prizes invigorate Japan’s bio industry

October 8, 2025

News

BioWorld

Tamra Sami

Bio Japan 2025 was abuzz with the news that Japan has once again snagged the Nobel Prize in Physiology or Medicine, with Shimon Sakaguchi winning…

Latest Press Releases & News

RegCell Announces Two Peer-Reviewed Publications Supporting its Robust Scientific Foundation on Antigen-Specific Tolerance to Treat Autoimmune Diseases

RegCell Scientific Founder and Board Member Dr. Shimon Sakaguchi Awarded Nobel Prize in Physiology or Medicine

Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition

RegCell Appoints Leading T-Cell Therapy Expert Steven B. Kanner, Ph.D., to Board of Directors

RegCell Appoints Experienced Life Science Executive and Entrepreneur Michael McCullar, Ph.D., MBA, as its New Chief Executive Officer

Scientists rehabilitate disease-causing T cells into tolerance builders

Science Spotlight: Autoimmune Treg therapy from Nobel Prize winner Sakaguchi

In 2 papers, Nobel winner debuts technique to turn rogue T cells into their own treatment

Viewpoint: Japan is on the cusp of a tech commercialisation revolution

Nobel winner Sakaguchi hopes to harness regulatory T-cells against cancer

Clarivate Repeats Success in Nobel Prize Predictions with 6 New Laureates Identified by Citation Laureates Program

Trio win Nobel economics prize for work on innovation, growth and ‘creative destruction’

Nobel winners still pushing boundaries in Treg innovation

Dr. Michael McCullar, PhD – CEO, RegCell – Restoring Self Tolerance To The Immune System

Shifumi Sakaguchi’s company will conduct the first clinical trial of regulatory T cells

How T regs fueled a new class of immunology companies

Bio Japan 2025: Nobel Prizes invigorate Japan’s bio industry

Contact Us

Find out more about how we are restoring self tolerance to the immune system to transform the treatment of autoimmune diseases.